Thomas E. Timbie, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 300,000 shares at $18.56 ($5.6M) on 2022-08-04, disclosed to the SEC on 2022-08-05.
Open-market sale of $5.6M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.85 | 96,879 | $1.8M | 32.4% |
| 2 | $18.85 | 96,879 | $1.8M | 32.4% |
| 3 | $18.56 | 48,217 | $895K | 15.9% |
| 4 | $18.56 | 48,217 | $895K | 15.9% |
| 5 | $19.04 | 4,904 | $93K | 1.7% |
| 6 | $19.04 | 4,904 |
| $93K |
| 1.7% |
| Total | $18.76 avg | 300,000 | $5.6M | 100% |
| Filing → |
| TMCI | SELL | 2023-01-20 | $1.3M | — | Filing → |
| TMCI | SELL | 2022-12-16 | $1.2M | — | Filing → |
| TMCI | SELL | 2022-11-22 | $2.2M | — | Filing → |